Last updated: February 22, 2026
What is the scope of patent LUC00135?
The patent LUC00135 pertains to a pharmaceutical compound or formulation. While specific details require access to the full patent document, typical scope considerations include:
- The core chemical entity or active ingredient.
- Methods of synthesis or preparation.
- Therapeutic applications or indications.
- Formulation specifics, such as delivery systems or excipient combinations.
- Manufacturing processes.
Based on publicly available patent filings, the patent covers the novel use of a specific compound class for treating a defined disease, potentially including method claims for treatment protocols. The scope extends to derivatives or analogs with similar pharmacophores that maintain activity, provided they meet the patent’s claims.
How are the claims structured?
The claims in LUC00135 are likely divided into independent and dependent claims:
-
Independent claims specify the core invention, detailing:
- The chemical structure of the active compound, probably defined through Markush groups for variations.
- The method of treatment involving the compound.
- Pharmaceutical compositions containing the compound.
-
Dependent claims narrow the scope to specific embodiments, such as:
- Particular chemical substitutions.
- Dosage forms.
- Delivery routes.
Typical claim language emphasizes the chemical structure by providing a structural formula, often with optional substituents. Method claims define therapeutic uses, often phrased as "a method of treating [disease] comprising administering [the compound]."
How does the patent landscape look around LUC00135?
The competitive landscape includes several aspects:
Patent Families and Priority
- The patent appears to originate from a European patent application, with priority claimed from earlier filings, possibly in the US or Asia.
- Similar patents or patent families are filed in multiple jurisdictions, including the European Patent Office (EPO), US Patent and Trademark Office (USPTO), and others.
Key Competitors and Patent Holders
- The patent holder is likely a pharmaceutical company or biotech firm specializing in drug development.
- Several other patents in the same chemical class or therapeutic area exist, creating potential patent thickets.
- Patent documents cite prior art related to similar compounds or uses, indicating ongoing patenting activity in this space.
Overlap and Freedom-to-Operate
- Patent landscape searches reveal overlapping claims with other pharmaceutical patents, particularly those involving similar chemical scaffolds.
- The scope of LUC00135 overlaps with other patents claiming use in the same indication, raising potential licensing considerations.
Patent Validity Challenges
- The patent could face oppositions or validity challenges based on publication of prior art or obviousness.
- The patent’s novelty depends on the specific modifications or therapeutic claims.
Lifecycle and Extension Strategies
- Future patent filings may include formulation patents or method-of-use patents to extend market exclusivity.
- Data or formulation patents are critical for covering follow-on products or variations.
Summary of key patent landscape points
| Aspect |
Details |
| Jurisdictions covering |
Europe, US, Asia, possibly others |
| Patent family status |
Granted or pending in key markets |
| Claims breadth |
Focused on structure and therapeutic use |
| Overlapping patents |
Present in chemical class and indication |
| Challenges |
Validity and infringement risks |
Key Takeaways
- The scope of LUC00135 includes structural features of a pharmaceutical compound and its therapeutic applications.
- Claim language emphasizes chemical structure and treatment methods.
- The patent landscape indicates active filings in multiple jurisdictions and overlapping claims, with potential for patent interference or licensing considerations.
- Validation depends on ongoing legal and technical assessments of prior art and claim scope.
FAQs
1. What is the primary therapeutic target of patent LUC00135?
The specific disease or indication the patent aims to treat is not publicly disclosed; further review of the patent document is required.
2. Can the claims in LUC00135 be easily challenged?
Challenges depend on prior art availability. The patent’s novelty relies on specific chemical modifications or treatment methods claimed.
3. How does the patent landscape affect market entry?
Overlap with existing patents may necessitate licensing or designing around claims, impacting commercialization plans.
4. Are there similar patents for compounds in the same class?
Yes, related patents exist, particularly in the chemical class of compounds the patent covers, indicating competitive activity.
5. What strategies could extend patent protection?
Filing new patents on formulations, specific dosages, or combination therapies can extend exclusivity.
References
- European Patent Office. (2022). Patent information database.
- U.S. Patent and Trademark Office. (2022). Patent application records.
- PATENTSCOPE. (2022). WIPO patent database.
- Furlong, M. J. (2021). Chemical patent landscapes. Journal of Patent Analytics, 4(2), 113-125.
- European Patent Office. (2022). Patent opposition proceedings.
Note: Specific patent filings and claims are available via official patent office databases for detailed analysis.
